Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2024
Companies covered: 16
Tables & Figures: 230
Countries covered: 19
Pages: 140
Download Free PDF

Topical Drug Delivery Market
Get a free sample of this reportGet a free sample of this report Topical Drug Delivery Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Topical Drug Delivery Market Size
The global topical drug delivery market size was valued at around USD 156.3 billion in 2024 and is estimated to grow at 8.8% CAGR from 2025 to 2034. Topical drug delivery techniques incorporate the administration of active substances through the skin or the mucous membranes to provide local or systemic effects.
This method includes the use of various formulations such as creams, gels, ointments, patches, or sprays which are meant to be applied to specific parts of the body. Topical delivery makes use of the skin's permeability to administer medications effectively at the application site.
The primary driver for growth within the topical drug industry stems from the surging skin-related problems and diabetes cases. Skin diseases affect about one-third of the global population, according to the British Journal of Dermatology. Furthermore, around 94 million Europeans are reported to suffer from skin burning, itching, and dryness according to The Journal of the European Academy of Dermatology and Venereology. Growth in the industry is also fueled by advancements in topical drug formulations and product launches in key areas.
For instance, in May 2022, Dermavant Sciences, Inc. gained U.S. FDA approval for Vtama (tapinarof) cream, which is the first steroid-free topical treatment for adult plaque psoriasis. In Europe, Almirall S.A. also launched Wynzora cream in February 2022 for the treatment of mild-to-moderate plaque psoriasis in adults.
Also, the increasing global occurrence of diabetes is one of the factors which is accelerating the growth of the topical drug delivery market. According to the International Diabetes Federation, approximately 537 million adults were suffering from diabetes in 2021, and this figure is expected to reach approximately 783 million by 2045. Moreover, diabetes may lead to various other complications such as pain in the lower limbs, and the introduction of topical treatments for these upper-layer conditions is a major reason driving market growth. An example is the FDA's Qutenza (capsaicin) approval in July 2020 for the treatment of diabetic neuropathic pain, which is a significant milestone in this area.
Topical Drug Delivery Market Trends
Trump Administration Tariffs
Topical Drug Delivery Market Analysis
Based on product, the market is segmented into semi-solid formulations, liquid formulations, solid formulations, and transdermal products. The semi-solid formulations segment is further sub-segmented into creams, ointments, lotions, gel, and pastes. Additionally, the liquid formulations segment is further sub-segmented into suspensions and solutions.
Furthermore, the solid formulations segment is further bifurcated into powders and suppositories. Moreover, the transdermal products segment is further bifurcated into transdermal patches and transdermal semi-solids. The global market was valued at USD 144.9 billion in 2024. The semi-solid formulations segment dominated the market with the largest revenue share of 62.1% in 2024.
Based on route of administration, the topical drug delivery market is segmented into dermal drug delivery, nasal drug delivery, ophthalmic drug delivery, vaginal drug delivery, and rectal drug delivery. The dermal drug delivery segment dominated the market with the largest revenue share of 58.7% in 2024.
Based on end use, the topical drug delivery market is segmented into home care settings, hospitals and clinics, burn centers, and other end uses. The home care settings segment dominated the market with the largest revenue of USD 66.9 billion in 2024.
North America: The U.S. topical drug delivery market is projected to grow significantly, from USD 59.1 billion in 2023 to USD 149 billion by 2034.
Europe: The topical drug delivery market in UK is expected to experience significant and promising growth from 2025 to 2034.
Asia Pacific: Japan topical drug delivery market is anticipated to witness lucrative growth between 2025 – 2034.
Middle East and Africa: The topical drug delivery market in Saudi Arabia is expected to experience significant and promising growth from 2025 to 2034.
Topical Drug Delivery Market Share
Galderma Laboratories, Teva Pharmaceutical Industries, Taro Pharmaceutical Industries, and GlaxoSmithKline as the top 4 players collectively held approximately 40% of the market share in the industry. The market contains both large global enterprises and countless smaller companies, making it rather competitive. Investing in the research and development of novel topical drug delivery systems, including microneedles, microneedle patches, nanotechnology-based drug delivery, as well as smart and wearable drug delivery systems, appears to be a vital strategy for wealthier participants in the market.
Further, strategic partnerships with research and healthcare institutions are important for integrating new technologies and for the widened distribution that enables companies to meet the growing need for non-invasive, low-cost diagnostic methods. Support from government regulations, including lowering the barriers to filing for innovation patents and the easing of the approval process for new therapeutics, encourages investment in novel ideas and competition in the market, thus signaling the fate of companies to profit off the expanding market.
Topical Drug Delivery Market Companies
Some of the eminent market participants operating in the topical drug delivery industry include:
Topical Drug Delivery Industry News:
The topical drug delivery market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:
Click here to Buy Section of this Report
Market, By Product
Market, By Route of Administration
Market, By End Use
The above information is provided for the following regions and countries: